How Creative Incubation Supports Life Sciences In The UKVicky Coghlan2024-11-28T14:38:23+00:00July 13th, 2023|Accelerator, BioCity Glasgow, Investment, News|
Commercializing The Success Of Scottish Life Sciences Will Rely On Scale-Up Space And Government DirectionVicky Coghlan2024-11-28T14:19:20+00:00June 14th, 2023|Article, BioCity Glasgow, Edinburgh Technopole, Investment|
HistologiX Adds Visiopharm To Their Histopathology WorkflowVicky Coghlan2024-12-05T12:34:22+00:00June 5th, 2023|BioCity Nottingham|
Drug Discovery Research Collaboration Announced By Sygnature Discovery And Daewoong PharmaVicky Coghlan2024-11-28T14:06:17+00:00April 24th, 2023|Article, BioCity Nottingham, News|
Pioneer Group Adds NunaBio To Venture Building ProgrammeVicky Coghlan2024-11-28T14:45:20+00:00April 21st, 2023|Investment, News|
Pioneer Group Launches Lab Building At Kent Science parkVicky Coghlan2024-11-28T14:47:21+00:00April 5th, 2023|Kent Science Park, News|
Agility Life Sciences Forge Strategic Partnership With SolitekVicky Coghlan2024-11-28T14:06:37+00:00April 3rd, 2023|Article, Headline Article, MediCity Nottingham, News|
Alveron Pharma Commences Clinical Trial Of New Intracranial Haemorrhage DrugVicky Coghlan2024-11-28T14:47:31+00:00March 31st, 2023|BioCity Nottingham, News|
Myconeos Innovate UK Smart Grant SuccessVicky Coghlan2023-03-28T14:48:14+01:00March 28th, 2023|BioCity Nottingham, News|
Life Sciences Investing: Pioneer Group Reinvests In Biotech Firm NuVisionVicky Coghlan2024-11-28T14:48:12+00:00March 9th, 2023|Accelerator, BioCity Nottingham, Investment, News|
